Pituitary
Pituitary adenoma
A benign tumour of the anterior pituitary that causes disease by the hormone it secretes (most often prolactin) or by pressing on the gland and its surroundings.
Causes and risk factors
- Prolactin-secreting adenomas are the commonest in adults (about 30%)
- Null-cell adenomas (about 20%) secrete no hormone
- Growth hormone-secreting adenomas are commoner in children
Gross pathology
- A mass in the sella turcica that can expand upwards.
Under the microscope
- Sheets of fairly uniform round cells with capillary channels; staining varies.
How it develops
- A clone of anterior pituitary cells forms an adenoma.
- Secreting adenomas cause syndromes of hormone excess.
- Non-secreting adenomas grow until they press on the gland (hypopituitarism) or the stalk.
Complications
- Hyperprolactinaemia, from a prolactinoma, or from stalk compression cutting off prolactin-inhibiting factor
- Hypopituitarism from mass effect
- Pressure on nearby structures
Investigations
- MRI of the pituitary
- The adenoma: a microadenoma (under 1 cm) or a macroadenoma that may press on the optic chiasm.
- Hormone tests
- Prolactin, IGF-1 (growth hormone excess), tests for cortisol excess, and tests for failing pituitary function.
- Visual field testing
- Bitemporal hemianopia when a macroadenoma compresses the optic chiasm.
Drug treatment
- Dopamine agonists (for pituitary tumours): Drugs that stimulate D2 receptors on lactotrophs, suppressing prolactin and shrinking prolactinomas; first-line treatment for prolactin-secreting pituitary adenomas.
- Somatostatin analogues: Long-acting versions of somatostatin that suppress growth hormone, gut hormones and splanchnic blood flow: used in acromegaly from pituitary adenomas, neuroendocrine tumours and bleeding oesophageal varices.
Anatomy involved
Written from
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 15, The Endocrine System, pp. 390, figs 15-7
Educational reference. Not medical advice, diagnosis or treatment.